Overview

Symptomatic Treatment of Common Cold Symptoms

Status:
Completed
Trial end date:
2007-06-01
Target enrollment:
Participant gender:
Summary
A two-arm, multicenter, randomized, double-blind, single dose placebo-controlled parallel groups study evaluating efficacy and tolerability of 800 mg Acetylsalicylic Acid (Aspirina C) in adult patients with a common cold during a two hour in patient phase; and a follow-up period of five days of home treatment as required.
Phase:
Phase 4
Details
Lead Sponsor:
Bayer
Treatments:
Aspirin